Navigation Links
Talk Show Host Shekhar Suman Plans to set up Heart Hospital in Patna

After filmmaker Prakash Jha and Bollywood actor-turned-politician Shatrughan Sinha, now popular talk show host Shekhar Suman has come up with a proposal to invest in his// home state - Bihar.

Suman has proposed to set up a cardiac hospital in his hometown here in memory of his son Ayush who died of a heart ailment many years ago.

The television star confirmed that he has put forward a proposal to set up an ultra modern heart hospital for children in Patna. Suman and his doctor father Phani Bhusan Das were granted instant appointment with Chief Minister Nitish Kumar Monday night.

After meeting Nitish Kumar, Suman said he had been assured that the state government would convey its decision on his proposal within a week. "It is time to give back to my native place," Suman told newspersons here.

According to him, the chief minister said that the state government would provide the land and other infrastructure needed for the hospital.

Suman, who spent his childhood and youth in Patna, said the proposed hospital would be ultra-modern.

He said he could not forget the pain of the death of his minor son, who died of a heart ailment when he was struggling to establish himself in Mumbai.

He said he would visit Patna regularly now and was proud to be born in Bihar and of his Bihari roots. "It is an emotional matter - a matter of the heart," he said.

His father resides in a middle class locality in Patna.

Suman is known for his comic takes on Bihar politicians, particularly Railway Minister Lalu Prasad.

Source-IANS
'"/>




Page: 1

Related medicine news :

1. Wockhardt Group Plans Hospital In Delhi By End-2007
2. Alberta’s New Reform Plans In Health Care Secto
3. Blue Cross Signs Up 110,000 Minnesotans For Part D Medicare Plans
4. Little Clinic LLC Plans Super Medical Clinics in Publix Super Markets
5. Medicare Drug Plans Are Onerous and Restrictive
6. Rajasthan Plans To Run Christian Institutions
7. Britains Bird Flu Contingency Plans Faces Criticism
8. Coraki Community Wants To Know About the Plans for the Campbell Hospital
9. Cadbury Plans to Dispose Monkhill
10. MP Plans Education Campaign To Attract School Dropouts
11. Imran Khan Plans To Open Second Cancer Hospital In Karachi
Post Your Comments:
(Date:12/1/2008)...ARLOTTE, N.C., Dec. 1 I..., Emeka Okafor, will be launching a mobile textin...can Lives Initiative (OMALI), a program of the Saf... the Initiative is to save one million lives in Af... blood testing kits and clinical training. , ...
(Date:12/1/2008)...NTA MONICA, Calif., Dec. 1 TOMS Sh...ched a holiday campaign online at TOMSshoes.com,...s holiday season. For 30,days, from November 20th...oppers to help give 30,000 pairs of shoes to child...ease that is 100% preventable by wearing shoes. By...
(Date:12/1/2008)..., , , , Ideas from U-M physician inc..., Mich., Dec. 1 A bottl...e are all quick and easy gifts to buy and wrap for...ot give something more healthy and beneficial to a... , Staying healthy around the holidays can be ...
(Date:12/1/2008)... JOLLA, Calif., Dec. 1 TorreyPines...nced that oral administration of NGX426, an,AMPA/...trated a statistically,significant reduction in s...d,pain state) and allodynia (pain resulting from ...d to placebo following intradermal injections of c...
Breaking Medicine News(10 mins):Health News:In Recognition of WORLD AIDS DAY, Charlotte Bobcats' Power Forward, Emeka Okafor, Launches Mobile Texting Campaign in Support of the One Million African Lives Initiative 2Health News:TOMS Shoes Embarks on a Holiday Mission: Give 30,000 Pairs in 30 Days! 2Health News:Giving the Gift of Health This Holiday Season 2Health News:Giving the Gift of Health This Holiday Season 3Health News:Giving the Gift of Health This Holiday Season 4Health News:TorreyPines' NGX426, an Oral AMPA/Kainate Receptor Antagonist, Meets Primary Endpoints in Reducing Capsaicin-Induced Pain in Healthy Subjects 2Health News:TorreyPines' NGX426, an Oral AMPA/Kainate Receptor Antagonist, Meets Primary Endpoints in Reducing Capsaicin-Induced Pain in Healthy Subjects 3Health News:TorreyPines' NGX426, an Oral AMPA/Kainate Receptor Antagonist, Meets Primary Endpoints in Reducing Capsaicin-Induced Pain in Healthy Subjects 4Health News:TorreyPines' NGX426, an Oral AMPA/Kainate Receptor Antagonist, Meets Primary Endpoints in Reducing Capsaicin-Induced Pain in Healthy Subjects 5
...als a new immune defense mechanism in normal airwa...ibrosis (CF) are particularly susceptible to bacte...the way to new approaches for treating the disease...enerate and use reactive oxygen species (ROS) to d...
...teroid, can prevent skin abnormalities induced by ...m the December //issue of the American Journal of ... Physiology. The new study also shows how psycholo...d initiate or worsen skin disorders such as psoria...
...g women who grow up in cities or move there from r...// Princess Diana was known to suffer from this e... in the country, and moved to London as a teenager...der in which young women get trapped in a routine ...
...e Family Restaurant at Lloydminister, has tested p...by a virus and affects the liver and causes fever,...iscomfort followed by yellow jaundice a few days l...ion of this virus from the worker to patrons of th...
Other Medicine News:Health News:Newly Discovered Immune Defense May Be Impaired In CF Airways 2Health News:Blocking Glucocorticoid Prevents Stress-Induced Skin Abnormalities 2Health News:Blocking Glucocorticoid Prevents Stress-Induced Skin Abnormalities 3
(Date:11/28/2008)...ll/ -- Eli Lilly and Company,(NYSE: LLY ) has w...DA) from,the U.S. Food and Drug Administration (F...gement of chronic pain. Lilly plans to resubmit th...ata from a recently completed positive study,in c...he decision does not affect duloxetine,s FDA-appro...
(Date:11/25/2008)... , Audio and Web Video Resources to accompan... Blog. Please see the bottom of this release for d... A Mayo Clinic study sho...re having a stroke -- and as a result -- delay see...findings appear in the current issue of Emergency ...
(Date:11/25/2008)...rstCall/ -- Pharmacyclics, Inc.,(Nasdaq: PCYC )...Phase 1,clinical trial with PCI-27483, the compan...IIa inhibitor. The trial was conducted in sixteen ...d pharmacologic effect of,PCI-27483. A single adm...,response in the International Normalized Ratio (...
(Date:11/24/2008)...stCall/ -- Leaders of Schering-Plough Corporation ...ors on the company,s research pipeline, highlighti...6 new entities in clinical trials or under regulat... "Research and development is adding strength an...ansformation," said Fred Hassan, chairman and CEO....
Breaking Medicine Technology:Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain 2Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain 3Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain 4Do You Know You're Having a Stroke? 2Do You Know You're Having a Stroke? 3Pharmacyclics Announces Completion of Phase 1 Clinical Trial of Factor VIIa Inhibitor PCI-27483 2Pharmacyclics Announces Completion of Phase 1 Clinical Trial of Factor VIIa Inhibitor PCI-27483 3Pharmacyclics Announces Completion of Phase 1 Clinical Trial of Factor VIIa Inhibitor PCI-27483 4Schering-Plough Highlights R&D Pipeline Progress, Innovation and Breadth of Research Projects 2Schering-Plough Highlights R&D Pipeline Progress, Innovation and Breadth of Research Projects 3Schering-Plough Highlights R&D Pipeline Progress, Innovation and Breadth of Research Projects 4Schering-Plough Highlights R&D Pipeline Progress, Innovation and Breadth of Research Projects 5Silent streams 3F Escalating endangerment for North American freshwater fish 4797 1Silent streams 3F Escalating endangerment for North American freshwater fish 4797 2Silent streams 3F Escalating endangerment for North American freshwater fish 4797 3Med School Diversity May Help Whites Care Better for Minorities 26203 1Med School Diversity May Help Whites Care Better for Minorities 26203 2Med School Diversity May Help Whites Care Better for Minorities 26203 3Young African American Males Face Mental Health Crisis 3B Experts Call For New Treatment Strategies and Better Access to Care 26199 1Young African American Males Face Mental Health Crisis 3B Experts Call For New Treatment Strategies and Better Access to Care 26199 2Young African American Males Face Mental Health Crisis 3B Experts Call For New Treatment Strategies and Better Access to Care 26199 3Medco CEO Unveils Pragmatic Blueprint for Health Care Reform 3B Reducing Costs by Upwards of 241 Trillion 26195 1Medco CEO Unveils Pragmatic Blueprint for Health Care Reform 3B Reducing Costs by Upwards of 241 Trillion 26195 2Medco CEO Unveils Pragmatic Blueprint for Health Care Reform 3B Reducing Costs by Upwards of 241 Trillion 26195 3Medco CEO Unveils Pragmatic Blueprint for Health Care Reform 3B Reducing Costs by Upwards of 241 Trillion 26195 4
...ata being presented today at Digestive Disease Wee...- Microbia today,announced the presentation of dat...rated colonic transit and improved bowel function,...le bowel syndrome,(IBS-C). These data also showed ...e of adverse events. Linaclotide is a first-in-cla...
...HEIM, Calif.--(BUSINESS WIRE)--May 21, 2007 - Anti...nal follow-up data on the,company,s Phase 3 invest...(vitespen). The end-of-study results, which reflec... that in a substantial,subset of patients (n = 362...ophage demonstrated a clinically significant,impro...
Other Medicine Technology:Microbia Announces Positive Phase 2 Results for Its Investigational,Compound Linaclotide 2Microbia Announces Positive Phase 2 Results for Its Investigational,Compound Linaclotide 3Microbia Announces Positive Phase 2 Results for Its Investigational,Compound Linaclotide 4Oncophage Cancer Vaccine Significantly Prolongs Recurrence-Free,Survival by 45 Percent in Patients With Intermediate-Risk Kidney,Cancer 2Oncophage Cancer Vaccine Significantly Prolongs Recurrence-Free,Survival by 45 Percent in Patients With Intermediate-Risk Kidney,Cancer 3Oncophage Cancer Vaccine Significantly Prolongs Recurrence-Free,Survival by 45 Percent in Patients With Intermediate-Risk Kidney,Cancer 4Oncophage Cancer Vaccine Significantly Prolongs Recurrence-Free,Survival by 45 Percent in Patients With Intermediate-Risk Kidney,Cancer 5Oncophage Cancer Vaccine Significantly Prolongs Recurrence-Free,Survival by 45 Percent in Patients With Intermediate-Risk Kidney,Cancer 6
Tube for Left Bronchus - Ruschelit™ PVC. Color coded for easy identification of ports, balloons and 15mm connectors. High volume/low pressure cuffs. X-ray opaque line. Graduated. Single use. St
...Medication Delivery., ,Designed for adolescent an... an additional lumen and injection port for rapid ...hree endotracheal tubes designs which allow for CO...livery without additional adaptors., ETCO2™ ...
...otracheal Instillation of Topical Anesthetic, ,De...cuffed tube incorporates an additional lumen and i...sthetic above and below the cuff., ,SHERIDAN offe...r CO2 monitoring, pressure monitoring or medicatio...
...oring Lumen., ,Designed for neonatal and pediatri...tube incorporates a monitoring lumen within the wa...er lock connector bonded to lumen line provides co...onitoring or syringe irrigation of medication., ,...
Medicine Products: